How can you tell if a scientific study is good? Learn what to look for in reliable studies and whether a trial may be right for you. https://t.co/dH4G0PHPfK
A tumor board brings together experts in different treatment fields to discuss your case and help direct your pancreatic cancer treatment. https://t.co/tjAFd1KQUS
Do you want to understand more about how your doctor chooses your treatments? Learn about the standard of care for pancreatic cancer. https://t.co/hDSmYmFv0u
An oncology pharmacist plays an important role on a patient’s care team. Learn more from Dr. Tammy McClellan about what oncology pharmacists do. https://t.co/dqt49gGYw6
Pancreatic neuroendocrine tumor patient Burt Rosen uses artificial intelligence to help him understand medical data, and to make him laugh. https://t.co/nSknFJj390
Do you have questions about the newly approved drug Rasonque, generic name daraxonrasib? You can find answers to all your questions on this page from our partner, @letswinpc. https://t.co/NpHJKi5xss
We are saddened to share Dr. Rachna Shroff, a member of our Scientific Advisory Board, has passed away. A physician-scientist and tireless advocate for clinical trials, she made a lasting difference for people facing pancreatic cancer. Our 💜 is with her family and loved ones.
Brooke Dwars learned quickly to manage her husband’s care. Nurse navigator Patricia Gambino and social worker Lauren Shaffer provide other tips for a caregiver. https://t.co/uidQbNxZVK
Dr. Despina Siolas is focusing her research on new treatments for pancreatic cancer, particularly ones that go after KRAS mutations. https://t.co/M0IL7vs1FT
Engineering T cells for immunotherapy vs cancer had already had marked success in certain types. But there's a next generation in the hopper, as reviewed today @Cancer_Cell, that ought to help take the field much further into solid tumors
https://t.co/FJd3qn4KuM
The AACR-Lustgarten Foundation Career Development Awards for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg and John Robert Lewis, are 3-year, $300,000 grants to support new ideas that advance pancreatic cancer research. Apply by Nov 20:
https://t.co/qoJNUWaaOt
The @SU2C Nina Nicolai Pancreatic Cancer Innovation in Collaboration Award provides up to $225,000 over 1-2 years to support bold, collaborative research in pancreatic cancer. Priority will be given to new SU2C collaborations. Apply by December 10:
https://t.co/ybxNlWPwVs
Durante este Mes de la Herencia Hispana, el Dr. Dean Xerras, miembro de la junta de Let's Win y médico de atención primaria, explica por qué los recursos en español son esenciales para los pacientes y las familias que enfrentan el cáncer de páncreas.